DES market revenues have been flatenning over the past 3 years. In 2019, DES national tariffs (LPPR) decreased of -17.1% (€760 to €630) even though it doesn't reflect real-life tariffs, especially in public hospitals where prices are much lower. Consequently we observe a drop of -3.4% in total revenues (2018 vs 2019 : €201M.). To get the full report, please contact-us : inquiries@ihmt-medicaldevice.com #DES #Coronary #Stent #Angioplasty #Heart #Interventional #Cardiology #Inf

In France, the new coronary drug eluting stent (DES) named Supraflex (Sahajanand Medical Technologies - SMT) will be reimbursed €630 from June 09, 2020 #SAHAJANANDMEDICALTECHNOLOGIES #SMT, #Coronary #Stent #DES #Sirolimus #Heart #Infarctus #cardiology #interventional #percutaneous #Supraflex #LPPR #Reimbursement #Marketaccess #Listing #Listeensus #Tariff #Addonpayment #France #Remboursement #Accesaumarché #Tarif #Inscription #cardiologie #Coronaire #interventionnelle #Angiopl

#Biotronik #Pantera #Lux #Coronary #Balloon #Stent #Angioplasty #Heart #Disease #Listeensus #ListeV #LPPR #Reimbursement #Marketaccess #Listing #Tariff #Addonpayment #France #Coronaire #Angioplastie #Remboursement #Accesaumarché #Tarif #Inscription #Paiement

#BBraun #Sequent #Please #Coronary #Balloon #Stent #Angioplasty #Heart #Disease #Listeensus #ListeV #LPPR #Reimbursement #Marketaccess #Listing #Tariff #Addonpayment #France #Coronaire #Angioplastie #Remboursement #Accesaumarché #Tarif #Inscription #Paiement